Q3 EPS Estimates for Cinemark Reduced by Barrington Research

Key Points

• Barrington Research has reduced its Q3 2025 EPS estimate for Cinemark to $0.40 per share, down from $0.42.
• The current consensus full-year earnings estimate for Cinemark is $1.93 per share, with future earnings projections indicating growth through FY2027.
• Cinemark's stock performance estimates show a market capitalization of $3.05 billion and a price-to-earnings ratio of 14.49.

Cinemark Holdings Inc (NYSE:CNK - Free Report) - Analysts at Barrington Research cut their Q3 2025 earnings estimates for shares of Cinemark in a research report issued on Thursday, October 16th. Barrington Research analyst P. Sholl now expects that the company will earn $0.40 per share for the quarter, down from their previous estimate of $0.42. Barrington Research has a "Outperform" rating and a $36.00 price target on the stock. The consensus estimate for Cinemark's current full-year earnings is $1.93 per share. Barrington Research also issued estimates for Cinemark's Q4 2025 earnings at $0.64 EPS, FY2025 earnings at $1.41 EPS, Q2 2026 earnings at $0.88 EPS, Q4 2026 earnings at $0.68 EPS, FY2026 earnings at $2.04 EPS and FY2027 earnings at $2.49 EPS.

Other equities analysts have also recently issued research reports about the stock. Zacks Research upgraded shares of Cinemark from a "strong sell" rating to a "hold" rating in a research note on Friday, October 3rd. Benchmark restated a "buy" rating and set a $35.00 target price on shares of Cinemark in a research note on Wednesday, July 2nd. Roth Capital lowered their target price on shares of Cinemark from $36.00 to $34.00 and set a "buy" rating on the stock in a research note on Monday, August 4th. Deutsche Bank Aktiengesellschaft initiated coverage on shares of Cinemark in a research note on Thursday, July 10th. They set a "buy" rating and a $36.00 target price on the stock. Finally, Weiss Ratings restated a "hold (c+)" rating on shares of Cinemark in a research note on Wednesday, October 8th. Nine investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus price target of $35.40.

Cinemark Stock Performance

Shares of CNK stock opened at $26.51 on Friday. The company has a debt-to-equity ratio of 4.32, a quick ratio of 0.88 and a current ratio of 0.91. The company has a market capitalization of $3.05 billion, a price-to-earnings ratio of 14.49, a price-to-earnings-growth ratio of 1.91 and a beta of 1.75. The company's 50-day moving average is $26.79 and its 200 day moving average is $28.73. Cinemark has a one year low of $23.12 and a one year high of $36.28.

Cinemark (NYSE:CNK - Get Free Report) last announced its quarterly earnings data on Friday, August 1st. The company reported $0.63 EPS for the quarter, missing the consensus estimate of $0.78 by ($0.15). Cinemark had a net margin of 9.13% and a return on equity of 59.16%. The firm had revenue of $940.50 million for the quarter, compared to analysts' expectations of $942.14 million. During the same period last year, the company posted $0.32 earnings per share. The business's revenue for the quarter was up 28.1% compared to the same quarter last year.

Cinemark Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, September 10th. Stockholders of record on Wednesday, August 27th were paid a $0.08 dividend. This represents a $0.32 annualized dividend and a dividend yield of 1.2%. The ex-dividend date was Wednesday, August 27th. Cinemark's dividend payout ratio is 17.49%.

Insider Buying and Selling at Cinemark

In other news, EVP Melissa Thomas sold 7,200 shares of the stock in a transaction that occurred on Friday, August 15th. The shares were sold at an average price of $25.17, for a total value of $181,224.00. Following the transaction, the executive vice president owned 203,768 shares in the company, valued at $5,128,840.56. This represents a 3.41% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 2.10% of the stock is owned by company insiders.

Institutional Investors Weigh In On Cinemark

A number of institutional investors and hedge funds have recently added to or reduced their stakes in CNK. EverSource Wealth Advisors LLC raised its stake in Cinemark by 118.5% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 935 shares of the company's stock worth $28,000 after acquiring an additional 507 shares during the period. Elevation Point Wealth Partners LLC bought a new stake in Cinemark during the 2nd quarter worth approximately $47,000. Russell Investments Group Ltd. raised its stake in Cinemark by 242.9% during the 1st quarter. Russell Investments Group Ltd. now owns 3,532 shares of the company's stock worth $88,000 after acquiring an additional 2,502 shares during the period. GAMMA Investing LLC raised its stake in Cinemark by 66.2% during the 2nd quarter. GAMMA Investing LLC now owns 3,474 shares of the company's stock worth $105,000 after acquiring an additional 1,384 shares during the period. Finally, CWM LLC raised its stake in Cinemark by 20.6% during the 1st quarter. CWM LLC now owns 6,548 shares of the company's stock worth $163,000 after acquiring an additional 1,118 shares during the period.

Cinemark Company Profile

Cinemark Holdings, Inc, together with its subsidiaries, engages in the motion picture exhibition business. As of February 16, 2024, it operated 501 theatres with 5,719 screens in 42 states and 13 countries in South and Central America. Cinemark Holdings, Inc was founded in 1984 and is headquartered in Plano, Texas.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.